Arius Pharmaceuticals Inc

Eisai is a human-centered pharmaceutical company located in Raleigh, NC. They focus on revolutionizing drug discovery and developing targeted medicines for challenging neurological conditions, primarily Alzheimer’s disease. Their commitment to pursuing breakthrough solutions is evident in their innovative approach to science and deep understanding of human biology. With a strong emphasis on oncology, Eisai is dedicated to accelerating progress towards a cancer-free world by allowing science to drive them to new approaches. They focus on addressing both the causes and symptoms of challenging diseases, striving to help patients whose needs might otherwise be overlooked. Eisai's patient-focused approach is reflected in their community involvement, corporate responsibility, and patient programs. By spending time understanding the needs of the people they serve, Eisai is able to provide cutting-edge therapies and support to patients and their families worldwide. Generated from the website content

Akta Pharmaceutical Development is an international company with headquarters in Raleigh, NC, and branches in Sweden, Canada, and Germany. Specializing in providing expertise to biopharmaceutical and private investment companies, academic institutions, and government clients, they facilitate the development of various products including new chemical entities, biosimilars, biologicals, and medical devices. With a mission to be in action for all beings and leverage resources to extend reach, AktaPD offers seasoned pharma experts to assist in the development of meaningful products such as cell therapies, beneficial bacteria, diagnostics, and foods. Their flexible approach allows them to work globally, ensuring they can support clients wherever and whenever needed.Generated from the website

QOL Medical is a specialty biopharmaceutical company based in Raleigh, NC, dedicated to improving the lives of patients with rare and orphan diseases. With a focus on solving complex healthcare challenges, QOL Medical aims to change the world one patient at a time. They provide expanded clinical awareness and patient access for the treatment of these rare diseases, currently marketing two FDA-approved products: Sucraid sacrosidase Oral Solution and Ethamolin ethanolamine oleate Injection, 5. Committed to ensuring an improved quality of life for patients, QOL Medical is interested in acquiring or partnering on biopharmaceutical products specifically designed for the treatment of rare diseases. With policies and procedures in place to meet the requirements of the highly regulated healthcare industry, QOL Medical strives to make a positive impact in the lives of those affected by these challenging conditions.Generated from the website